Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Critical Illness, Enteral Feeding
Interventions: VITAL AF, Osmolite 1.2; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Sleep Deprivation, Nutritional Intervention
Interventions: Ketogenic Intervention, Mediterranean Intervention, Placebo, Ketone Ester; Other · Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hypertension
Interventions: Revision of congregate meal menus and recipes to align with parameters of DASH eating plan, On-site blood pressure monitoring, Home self blood pressure monitoring, Medical adherence education, Nutrition Education; Behavioral
Lead sponsor: Rockefeller University; Other
Eligibility: 60 Years to 105 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Systemic Lupus Erythematosus
Interventions: Omega-3, flow-mediated dilation of the brachial artery, corn starch; Drug · Device · Other
Lead sponsor: Michelle Petri M.D.,MPH; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Pediatric Bipolar Spectrum Disorders
Interventions: Omega-3, Inositol; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 5 Years to 12 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Venous Leg Ulcer
Interventions: Omeza® OCM™; Device
Lead sponsor: Omeza, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Los Angeles, California • Hollywood, Florida • North Port, Florida + 4 more

Conditions: Liver Injury
Interventions: Omegaven™, Historical Controls; Drug · Other
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: Up to 21 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Lipoprotein Metabolism, PCSK9, Proteomics
Interventions: EPA-rich fish oil, DHA-rich fish oil; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy Nutrition
Interventions: RiteStart Supplement; Dietary Supplement
Lead sponsor: 4Life Research, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Sandy City, Utah

Conditions: Preterm Birth
Interventions: Docosahexaenoic acid - 800mg/day, Docosahexaenoic acid - 200mg/day, Placebo; Drug · Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Kansas City, Kansas • Cincinnati, Ohio • Columbus, Ohio

Conditions: Benign Breast Disease
Interventions: Vitamin D and fish oil placebo, Fish oil and vitamin D placebo, Vitamin D placebo and fish oil placebo, Vitamin D and fish oil; Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 55 Years to 67 Years · Female only
Enrollment: 3,894 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Total Parenteral Nutrition-induced Cholestasis
Interventions: Omegaven®; Drug
Lead sponsor: Jeffrey Rudolph; Other
Eligibility: 2 Months to 10 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy
Interventions: Fish oil + wild orange essential oil supplement, Fish oil supplement; Dietary Supplement
Lead sponsor: dōTERRA International; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Pleasant Grove, Utah

Conditions: Periodontal Attachment Loss
Interventions: Omega-3 Fatty acid (with SRP or OHI), Placebo; Dietary Supplement
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Breast Cancer
Interventions: Mini rTG OMEGA-3 Fish Oil; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Schizophrenia, Schizoaffective Disorder, Major Depression, Bipolar Disorder, Coronary Artery Disease
Interventions: Eicosapentaenoic acid (omega-3 fatty acid), Placebo; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Polycystic Ovarian Syndrome
Interventions: Flax Seed Oil, Fish Oil, Soybean Oil; Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Obesity, Hypertriglyceridemia, Insulin Resistance, Hypertension
Interventions: Fish Oil, Flaxseed Oil, Placebo; Dietary Supplement
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hot Flashes, Menopause, Vasomotor Symptoms
Interventions: Placebo, Omega-3, Yoga, Exercise, Usual Activity; Dietary Supplement · Behavioral
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 40 Years to 62 Years · Female only
Enrollment: 355 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Oakland, California • Indianapolis, Indiana • Seattle, Washington

Conditions: Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis
Interventions: Omegaven™; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Dyslipidemia
Interventions: Alirocumab, Statins, Ezetimibe, Fenofibrate, Nicotinic acid, Omega-3 fatty acids, Antihyperglycemic Drug; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 413 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 57
States / cities: Little Rock, Arkansas • Fresno, California • Huntington Beach, California + 51 more

Conditions: Bone Density, Body Composition, Bone Health
Interventions: Vitamin D3 placebo, Fish oil placebo, omega-3 fatty acids (fish oil), Vitamin D3; Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years and older
Enrollment: 771 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cystic Fibrosis
Interventions: Docosahexaenoic acid (DHA), Standard formula (Enfamil); Dietary Supplement
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: Up to 56 Days
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 24
States / cities: Birmingham, Alabama • Atlanta, Georgia • Des Moines, Iowa + 19 more

Conditions: Healthy
Interventions: Placebo supplement, Citicoline and Omega-3 supplement, Omega-3 supplement; Dietary Supplement
Lead sponsor: Kyowa Hakko Bio Co., Ltd.; Industry
Eligibility: 55 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings

Ketone Conferred Resiliency Against Sleep Restriction With Nutritional Intervention.

DASH Diet Intervention at Senior Centers

Efficacy of Fish Oil in Lupus Patients

Inositol and Omega-3 Fatty Acids in Pediatric Mania

Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers

Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury

Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults

RiteStart Personal Nutritional Dietary Study

Assessment of DHA On Reducing Early Preterm Birth

VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue

Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury

Omega-3 Supplement and Health Markers

Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses

Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors

Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation

Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels

Effects of Omega-3 Fatty Acids on Markers of Inflammation

MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation

Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)

Use of Formula Fortified With DHA in Infants With Cystic Fibrosis

The Combination Effect of Citicoline and Omega-3